Bastiaan Sallevelt

235 OPERAM: cluster randomised controlled trial Table 3. Continued. STOPP/ START Description Count in intervention group, N (%) Implemented, N (%) Not implemented, N (%) START A5 Statin therapy with a documented history of coronary, cerebral or peripheral vascular disease, unless the patient’s status is end-of-life or age is > 85 years 62 (2.7) 14 (22.6) 48 (77.4) This table presents the 10 most commonly identified STOPP/START criteria (22) of the overall 2,331 recommendations made. Implemented vs. not implemented refers to whether recommendations were implemented at month 2 after enrolment. START I1 and I2 criteria and some STRIPA generated signals that could not be interpreted as recommendations were omitted from the analysis. 1 The ten most commonly identified drug classes with no evidence-based indication were in descending order of frequency: antacids, mineral supplements, psychoanaleptics, lipid modifying agents, psychotropics, antithrombotics, vitamin, analgesics including opioids, drugs for constipation, and drugs for obstructive airway diseases. Abbreviations: NSAID, non-steroidal anti-inflammatory drugs; STOPP/START, Screening Tool of older People’s Prescriptions/ Screening Tool to Alert to right treatment. . 3

RkJQdWJsaXNoZXIy MTk4NDMw